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Abstract
Reduced telomere length (TL) and structural brain abnormalities have been reported in patients with schizophrenia
(SZ) and bipolar disorder (BD). Childhood traumatic events are more frequent in SZ and BD than in healthy individuals
(HC), and based on recent findings in healthy individuals could represent one important factor for TL and brain
aberrations in patients. The study comprised 1024 individuals (SZ [n= 373]; BD [n= 249] and HC [n= 402]). TL was
measured by quantitative polymerase chain reaction (qPCR), and childhood trauma was assessed using the Childhood
Trauma Questionnaire (CTQ). Diagnosis was obtained by the Structured Clinical Interview (SCID) for the diagnostic and
statistical manual of mental disorders-IV (DSM-IV). FreeSurfer was used to obtain regional and global brain volumes
from T1-weighted magnetic resonance imaging (MRI) brain scans. All analyses were adjusted for current age and sex.
Patients had on average shorter TL (F= 7.87, p= 0.005, Cohen’s d= 0.17) and reported more childhood trauma
experiences than HC (χ2= 148.9, p < 0.001). Patients with a history of childhood sexual, physical or emotional abuse
had shorter TL relative to HC and to patients without a history of childhood abuse (F= 6.93, p= 0.006, Cohen’s d=
0.16). After adjusting for childhood abuse, no difference in TL was observed between patients and HC (p= 0.12). There
was no statistically significant difference in reported childhood abuse exposure or TL between SZ and BD. Our analyses
revealed no significant associations between TL and clinical characteristics or brain morphometry. We demonstrate
shorter TL in SZ and BD compared with HC and showed that TL is sensitive to childhood trauma experiences. Further
studies are needed to identify the biological mechanisms of this relationship.
Introduction
Telomeres are DNA–protein structures at the tails of
chromosomes that shorten with increasing age in most
human tissues.1–3 Human telomeres are composed of
tandem repeats of the TTAGGG sequence and average
between 6 and 12 kilobases (kb) in length.1,3 When telo-
meres become critically short, the risk of apoptosis is
increased, and proliferation is arrested, which eventually
compromises tissue renewal capacity and function.4–6
Telomere length (TL) may, therefore, represent a ‘mole-
cular clock’ that contributes to aging.2,7 Studies report
shorter age-adjusted TL in schizophrenia (SZ),8 bipolar
disorders (BD),9 and in individuals at high risk for psy-
chosis.10 It has been proposed that the shorter the age-
adjusted TL, the more severe the illness, suggesting its
potential application for clinical staging and identification
of treatment needs.11 However, the strength of effect
remains unclear as one recent study even failed to repli-
cate the finding of shorter TL in SZ.12 Furthermore, the
knowledge is scarce about the biological sources of
potentially reduced TL in SZ/BD, and as discussed in the
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recent paper by Pepper et al.13 TL studies tend to be small
and therefore underpowered.
In healthy individuals, a growing body of evidence has
linked chronic stress and childhood traumatic events to
accelerated shortening of TL.14–17 However, whether
reduction of TL in SZ and in BD is linked to more fre-
quent and more severe exposure to early trauma experi-
ences18 is still not known. TL has emerged as an
encouraging peripheral biomarker of cumulative stress
and biological aging,15,16 but until now studies in SZ and
BD are lacking. Patients reporting childhood traumatic
events could be a subgroup of patients characterised by
shorter TL, which has not yet been addressed in previous
studies of SZ and BD.
On average, patients with SZ and BD have thinner
cerebral cortices and smaller subcortical and cerebellar
brain volumes compared with HC,19–22 with strongest
effect sizes for the frontal and temporal lobe regions and
the hippocampus. However, the mechanisms of the
observed group-level brain aberrations are largely
unknown. Among other factors, childhood trauma and
TL may represent confounding factors, but the current
knowledge is sparse regarding brain morphology and TL.
A large population-based study by King et al.23 comprised
of 1960 individuals reported a positive correlation
between TL and grey and white matter volume, with the
strongest associations in participants aged 50 years and
older. However, King et al. did not take into account the
role of having a severe mental disorder or reports of early
trauma, which we aim to investigate in the current study.
Here, we assessed if patients with SZ and BD had
shorter TL than HC from the same catchment area. We
further investigated if childhood abuse contributed to
attrition of TL in the patient group. Lastly, we tested for
associations between TL and clinical characteristics, as




The participants were recruited from psychiatric units
(outpatient and inpatient) of four major hospitals in
Oslo, as part of the Thematically Organised Psychosis
(TOP) Study, also called the NORMENT study. Eighty-
nine percent of the sample were Caucasian. A total of
1024 participants (with SZ [n= 373], BD [n= 249]) and
HC [n= 402]) were included. Inclusion criteria for the
HC were age between 18 and 65 years and having no
current or lifetime Axis 1 diagnosis from the diagnostic
and statistical manual of mental disorders-IV (DSM-
IV,24 MRI data were available from 711 individuals (SZ,
n= 198; BD, n= 173 and HC, n= 340). Exclusion cri-
teria for all groups included organic psychosis,
neurological disorder and unstable or uncontrolled
medical conditions interfering with brain function, and
age outside the range of 18–65 years. The Regional
Committee for Medical Research Ethics and the Nor-
wegian Data Inspectorate approved the study. All par-
ticipants gave written informed consent. The
participants were enroled between 2007 and 2016.
Clinical assessment
Trained physicians, psychiatrists and/or clinical psy-
chologists performed clinical assessments. Diagnosis was
obtained by the SCID for DSM-IV, chapters A–E. All
clinical personnel completed a training programme in
diagnostics and symptom rating, which was based on the
training programme at UCLA (Los Angeles, California)
(Ventura et al.25). The training programme is based on the
SCID 101 training videos and includes videos with relia-
bility testing between SCID scorers (http://www.scid4.
org/index.html). The diagnostic reliability in the NOR-
MENT sample has been found to be satisfactory with an
overall agreement on DSM-IV diagnostic categories of
82% and an overall κ of 0.77 (95% CI: 0.60–0.94).
Clinical characteristics
Number of episodes was calculated based on the SCID.
Duration of illness was defined as current age minus age
at the first SCID-verified episode. Current symptom level
was assessed by the Positive and Negative Syndrome Scale
(PANSS) (Kay et al.26), and current functioning was
measured by the Global Assessment of Functioning scale
(GAF).27
Childhood trauma
To measure childhood adverse events, we used the
Childhood Trauma Questionnaire (CTQ), a retrospective
questionnaire that assesses traumatic experiences in
childhood.28 The CTQ has answers ranging from ‘never
true', ‘rarely true', ‘sometimes true', ‘often true', to ‘very
true', and it yields a total score as well as five sub-scores:
physical, emotional and sexual abuse, physical and emo-
tional neglect28 (moderate-to-severe cut-off scores by
Bernstein et al.28 were used to classify individuals has
having or not having a history of childhood trauma. The
reliability and validity of the CTQ have been demon-
strated previously28,29. Owing to the high correlation
between CTQ neglect items and minimisation/denial
(MD) score18,30,31), we focused our main analyses on
childhood abuse (sexual abuse, physical abuse and emo-
tional abuse) using moderate-to-severe cut-off scores.
Abuse variables (sexual abuse, physical abuse and emo-
tional abuse) reaching moderate-to-severe cut-off score
for abuse were collapsed into a total childhood abuse
score.
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TLs measurement
Peripheral leucocyte TL was measured following a
previously published quantitative real-time polymerase
chain reaction (PCR) method with some modifications.32
Briefly, the abundance of telomeric template versus a
single copy gene (36B4) was estimated by PCR on 10 ng of
DNA, with 5 µl SYBR®Green JumpStart Taq Ready Mix
and 0.25 µl of ROX reference dye (Sigma-Aldrich, Gil-
lingham, UK) and the following primers: 300 nM TelA
(5′-CGG TTT GTT TGG GTT TGG GTT TGG GTT
TGG GTT TGG GTT-3′); 900 nM TelB (5′-GGC TTG
CCT TAC CCT TAC CCT TAC CCT TAC CCT TAC
CCT-3′) for the telomeric reaction and 200 nM 36B4F (5′-
CAG CAA GTG GGA AGG TGT AAT CC 3′) and
400 nM 36B4R (5′-CCC ATT CTA TCA ACG GGT ACA
A-3′) for 36B4. All samples were assessed in triplicate and
all PCRs were carried out on an Applied Biosystems
7900HT Fast Real Time qPCR system with 384-well plate
capacity. Three internal control DNA samples of known
TL (10.4 kb, 3.9 kb and 2 kb) were run within each plate to
correct for the plate-to-plate variation. As a further
authentication of our TL measurements, we performed a
revaluation of those samples that were in either the 5%
top or 5% bottom of the TLs distribution as well as those
samples that gave no valid data on the first run. The intra-
assay coefficient of variation was 6.07% while the inter-
assay coefficient of variation was 6.08%. Telomeres were
defined by the ratio telomere template/amount of single-
copy gene template in the direction of smaller number
indicating shorter average TL. TL was measured in blood
only. Blood samples were stored and extracted from the
Biobank in Oslo, Norway.
MRI data
MRI scans were obtained from three different scanners
at Oslo University Hospital, Ullevål. One-hundred and
seventy-eight scans were acquired using a 1.5 T Siemens
MAGNETOM Sonata scanner (Siemens Medical Solu-
tions, Erlangen, Germany) supplied with a standard head
coil. For each participant, two T1-weighted images were
acquired using a repeated 3D T1-weighted magnetisation
prepared rapid acquisition gradient echo (MPRAGE)
sequence with the following parameters: repetition time
(TR)= 2730ms, echo time (TR)= 3.93 ms, inversion time
(TI)= 1000 ms, field of view (FOV)= 240mm, flip angle
(FA)= 7 o, matrix= 192 × 256, voxel size= 1.33 × 0.94 ×
1mm, 160 sagittal slices. The two T1-weighted scans
obtained for each participant were averaged after rigid
registration to improve signal-to-noise ratio (SNR). In
total, 147 scans were obtained using a 3 T General Electric
Signa HDxt scanner with an eight-channel head coil. A
sagittal T1-weighted FSPGR sequence was collected with
the following parameters [TR= 7800 ms; TE= 2.956 ms;
TI= 450 ms, flip angle= 12 o; in-plane resolution= 1 ×
1mm; number of slices= 166; slice thickness= 1.2 mm;
acquisition time= 7min 8 s]. Lastly, 386 scans were
obtained using a 3 T General Electric 750 Discovery
scanner with a 32-channel head coil. A 3D IR-prepared
fast spoiled gradient echo (FSPGR) T1-weighted sequence
(3-D BRAVO) was collected with the following para-
meters: TR/TE / flip angle/voxel size/FOV/ slices/scan
time= 8.16 ms, 3.18 ms, 12°, 1 × 1 × 1mm, 256 × 256mm,
188 sagittal slices, 4:42 min.
MRI volumes were processed using the standard Free-
Surfer recon-all stream (v.5.3, http://surfer.nmr.mgh.
harvard.edu), deriving anatomical segmentations of cor-
tical and subcortical structures, and an estimate of total
intracranial volume (ICV).
Statistical analysis
Statistical analyses were performed using the IBM SPSS
software, version 25.33 Continuous variables are sum-
marised as mean ± SD. Analysis of covariance (ANCOVA)
was applied to investigate if patients had shorter TL than
controls, with and without adjusting for moderate-to-
severe childhood abuse (both group status and abuse were
added as fixed factors, see Table 2). Age and sex were
adjusted for in the models. For the ANCOVA analyses,
information on childhood abuse from the CTQ was
dichotomised into < or ≥ the moderate-to-severe cut-off
score by Bernstein28 see Supplementary Material Table
S1. We computed Cohen’s d as an estimate of effect size.34
For the primary analyses (TL and case/control compar-
isons), the threshold for statistical significance was set at
p < 0.05 with Post hoc Bonferroni corrections. Medication
and TL were tested one by one, as well as a cumulative
variable «TL and antipsychotic medication (yes/no)+
mood stabilisers (yes/no) and antidepressant (yes/no) ».
ANCOVA was also applied to investigate the relation-
ship between TL and clinical characteristics, as well as
between TL and brain regions. For the TL and clinical
analyses, the following variables were included one at a
time: duration of illness, number of mood episodes, GAF
and PANSS. All analyses were corrected for age, sex and
diagnosis. We adjusted for number of clinical variables,
yielding a significant threshold of p= 0.05/4= 0.013.
Brain regions were chosen based on regions previously
reported to be reduced in SZ and BD.20,22,35 As over-
lapping brain region changes are reported in SZ and
BD,20,22,35 patients were analysed as one group. As three
types of scanners were used in the study, we covaried for
scanner in the analyses. For the TL and brain regions
analyses, we corrected for the number of brain regions
investigated (10 subcortical structures, and seven regions
for cortical thickness/surface area, giving a significant
threshold of p= 0.05/17= 0.003).
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Results
Sample characteristics
Sociodemographic and clinical characteristics of the
total sample (n= 1024) divided into diagnostic groups
(BD, SZ) and HC are shown in Table 1. There were sig-
nificantly more females in the BD group, compared with
SZ or HC. Moreover, SZ were significantly younger than
BD and HC. Across groups, 521 patients (84%) were
taking regular current antipsychotic medication, 163
(26%) current mood stabilisers and 181 (29%) anti-
depressant medication. HC reported less childhood mal-
treatment (CTQ total score) compared with SZ and BD
(X2= 148.9, p < 0.001). Post hoc Bonferroni corrected
analyses revealed no difference in reports of childhood
maltreatment between the patient groups (SZ vs. BD). In
the total sample, females were more likely to report at
least one type of childhood abuse reaching levels of
moderate- to-severe abuse by Bernstein et al.28 In total,
28% of all females included in the study reported child-
hood abuse, compared with 19% of males (X2= 10.40, p
= 0.001), see Supplementary Material Table S2.
TL in patients and HC
Patients (mean ± SD, 1.12 ± 0.27) had significantly
shorter TL than the HC (mean ± SD 1.16 ± 0.20, F= 7.87,
DF= 1, p= 0.005, Cohen’s d= 0.17). Post hoc tests
revealed that TL was not significantly different in BD
(mean ± SD, 1.13 ± 0.28) compared with SZ (mean ± SD,
1.11 ± 0.26, F= 0.68, p= 0.41). Within the patients, there
was no association between TL and number of psychotic
or mood episodes, duration of illness, GAF or PANSS (p
> 0.1, see Supplementary Material Table S2). No sig-
nificant association was observed between current medi-
cation use (antipsychotic, mood stabilisers or
antidepressants) and TL (p > 0.1).
TL and childhood abuse
Pairwise comparisons revealed a significant difference in
TL between patients with childhood abuse (mean ± SD
1.099 ± 0.26) compared with HC (F= 12.62, p= 0.003,
Cohen’s d= 0.26, see Fig. 1), with no difference in TL
between patients without childhood abuse (mean ± SD
1.13 ± 0.27) and HC (F= 3.73, p= 0.13, Cohen’s d=
0.11). Patients with a history of childhood abuse had
shorter TL relative to HC and to patients without a his-
tory of childhood abuse (F= 6.93, p= 0.006, Cohen’s d=
0.16). After adjusting for childhood abuse, no statistical
significant difference in TL between patients and HC was
observed (F= 2.19, p= 0.12). Dividing into subtypes of
trauma, only emotional abuse was statistical significantly
associated with TL (see Supplementary Material Table 3).
Table 1 Demographics of the sample
SZ BD HC Statistics Post hoc analyses
Age, mean ± SD 29.1 ± 9.3 31.8 ± 11.3 31.4 ± 7.6 F= 8.39, p < 0.001 SZ < BD, HC
Sex, N (%), males 221 (59) 103 (42) 228 (57) X2= 20.8, p < 0.001 BD < SZ, HC
CTQ, total score, mean ± SD 43.8 ± 15.5 43.3 ± 17.0 29.6 ± 5.2 F= 137.9, p < 0.001 HC < SZ, BD
Emotional abuse, mean ± SD 10.5 ± 0.2 10.5 ± 0.2 6.2 ± 0.2 F= 132.0, p < 0.001 HC < SZ, BD
Sexual abuse, mean ± SD 6.5 ± 3.3 6.7 ± 3.7 5.1 ± 0.8 F= 34.9, p < 0.001 HC < SZ, BD
Physical abuse, mean ± SD 7.0 ± 0.2 6.9 ± 0.2 5.2 ± 0.2 F= 45.2, p < 0.001 HC < SZ, BD
Daily smoking, yes (%) 220 (60) 132 (53) − X2= 2.60, p= 0.11
BMI, mean ± SD 26.6. ± 5.6 25.8 ± 4.5 − F= 4.1, p= 0.04
CTQ Childhood Trauma Questionnaire, BMI body mass index, SD standard deviation, n number, SZ schizophrenia, BD bipolar disorder, HC healthy controls
Fig. 1 Patients with abuse have shorter telomeres than healthy
controls. ANCOVA, adjusted for age and sex, F= 5.13 p= 0.006,
partial eta squared= 0.01. Pairwise comparisons, Bonferroni adjusted;
HC compared with patients with abuse: p= 0.003, Cohen’s d= 0.26;
HC compared with patients without abuse: (p= 0.14). Patients no
abuse versus patients abuse (p= 0.36). HC, n= 401; Patients without
abuse, n= 393; and patients with abuse, n= 224. HC healthy controls,
TLtelomere length. T/S ratio= telomere template/amount of single
copy gene template. Lower score is a measure of shorter TL.
Childhood trauma was defined as having at least one type of abuse
reaching moderate-to-severe levels as defined by28
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TL and subcortical regions
We found no significant relationship between TL and
subcortical volumes. There was one nominally significant
association with amygdala volume (F= 7.61, DF= 1, p=
0.01, see Table 2); however, this did not survive correc-
tions for multiple comparisons.
TL, area and thickness within regions of interest
We found no significant relationship between TL and
cortical thickness or surface area after correction. Nom-
inally significant associations were observed between TL
and the superior frontal gyrus area (F= 3.73, DF= 1, p=
0.05), see Table 3, and frontal pole thickness (F= 2.28,
DF= 1, p= 0.04), see Table 4.
Discussion
Our study confirms significantly shorter TL in a large
sample of patients with SZ and BD compared with HC;
however, the effect size was small. Shorter TL was spe-
cifically observed in patients reporting childhood abuse.
No significant difference in TL was demonstrated
between patients and HC after adjusting for childhood
abuse. This suggests childhood abuse as an important
factor for reduced TL in SZ and BD compared with HC.
Patients reporting childhood abuse had the shortest TL,
suggesting a link between early stressors and accelerated
aging,15,36 which until now has not been reported in SZ or
BD. A history of childhood abuse has been linked to
shorter TL in a smaller sample of patients with a mental
illness (n= 290). However, this comprised of patients with
a lifetime depressive, anxiety or substance use disorder,
not SZ or BD.17 The biological mechanisms underlying
the present findings are, however, unclear. Research
emphasises the importance of early stressors on acceler-
ated aging, potentially via cortisol increase of oxidative
stress14 or cortisol reduction of blood levels of growth
hormone (GH).37 In the past decade, the growing field of
telomere science has opened exciting new avenues for
understanding the cellular and molecular substrates of
stress and stress-related aging processes over the lifespan.
Higher attrition of TL is associated with advanced
chronological age and potentially also with disease mor-
bidity and mortality, supported by patients with SZ and
BD having more than 10 years shorter life expectancy
than the general population.38,39 An intriguing link
between TL and SZ and BD could be long-term low-grade
inflammation, since cell senescence increases inflamma-
tion (Freund et al.40); the immune system has been sug-
gested to play a role in the pathophysiology of SZ and
BD41,42, especially in individuals with childhood abuse.43
Hence, the role of TL and inflammation in SZ and BD
needs further clarifications.
We found no significant associations between TL and
brain structures in our study. Reduced grey matter
Table 2 Telomere Length and subcortical regions
F DF p
Amygdala 7.61 1 0.01
Hippocampus 0.92 1 0.34
Cerebellum 1.06 1 0.31
Thalamus 1.13 1 0.29
Caudate <0.01 1 0.99
Putamen 0.05 1 0.83
Pallidum 2.52 1 0.11
Accumbens 0.09 1 0.76
Brainstem 0.97 1 0.33
Ventricles 1.23 1 0.27
Data were corrected for age, sex, ICV, group status (patients and controls) and
scanner
Table 3 Telomere length, cortical area within regions of
interest
F DF p
Frontal pole 141 1 0.24
MFG 1.34 1 0.25
SFG 3.73 1 0.05
MTG 0.16 1 0.69
STG 0.14 1 0.71
Lat Occip 0.01 1 0.95
SPG 0.22 1 0.64
MFG medial frontal gyrus, SFG superior frontal gyrus, MTG middle temporal
gyrus, STG superior temporal gyrus, Lat Occip lateral occipital gyrus, SPG superior
parietal gyrus. Data were corrected for age, sex, ICV, group status (patients and
controls) and scanner
Table 4 Telomere length and cortical thickness within
regions of interest
F DF p
Frontal pole 4.28 1 0.04
MFG 0.01 1 0.97
SFG 3.26 1 0.07
MTG <0.01 1 0.97
STG 0.13 1 0.72
Lat Occip 0.41 1 0.52
SPG 0.02 1 0.90
MFG medial frontal gyrus, SFG superior frontal gyrus, MTG middle temporal
gyrus, STG superior temporal gyrus, Lat Occip lateral occipital gyrus, SPG superior
parietal gyrus. Data were corrected for age, sex, group status (patients and
controls) and scanner
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volume reported in SZ and BD20,22,35 are unlikely to be
related to TL, but to other underlying disease mechan-
isms. Our study failed to show a link between shorter TL
and reduced brain regions previously shown in a
population-based study.23 The latter study included older
participants with a mean age of 50 years, compared with a
median age of 29 years in our study, suggesting that TL
may be more relevant for brain size in older individuals
accumulating effects over time.
Our study did not show an association between clinical
variables and TL. This is in contrast to Berk et al.11 sug-
gesting shorter TL as a biomarker of later clinical staging,
characterised by a more severe illness in BD.11 Similar to
the study by Elvsashagen et al.44 we did not find an
association between duration of illness and TL. Contrary
to the study by Elvsashagen et al.44 we did not find an
association between depressive episodes and TL. How-
ever, our study sample was 4–5 years younger on average
and was comprised of SZ and BD while the previous study
included bipolar II (BDII) only.
A few limitations to the present study should be men-
tioned: TL was measured in peripheral blood, and not in
the brain. Data from human and non-human primates
studies point to strong correlations between TL measured
across somatic tissues.45 However, the correlation
between TL in the brain and peripheral TL show incon-
clusive findings.37 The study by Dlouha et al.46 measuring
TL in 12 different tissues, found that TL in leucocytes
correlated with TL in the liver and intercostal muscle, but
not TL in the brain. We also measured average TL and
not number of short TL. It could be proposed that having
information on the percentage of shorter TL could give
more valuable information on aging and biological
senescence than average TL. Moreover, childhood trauma
was reported retrospectively, with the inherited weakness
of the retrospective design. However, retrospective
trauma questionnaires have been found to correlate with
case notes,47 suggesting retrospective interviews as a valid
instrument to collect data on childhood trauma. We also
focused on abuse items and not neglect items from the
CTQ since recent studies have shown that abuse items are
less likely to be biased by underreporting on the CTQ
questionnaire.18,30,31 However, it should be mentioned
that reliance solely on retrospective assessment methods
may have led to a proportion of non-exposed group being
misclassified and thus affecting the results.48,49 Further-
more, due to the low percentage of HC that reported
moderate-to-severe childhood abuse (n= 13, 3%), com-
pared with patients (n= 217, 39%), we were not able to
run an interaction analyses of group status and childhood
trauma on TL. Since information on BMI and smoking
status was limited in the control sample, we were not able
to adjust for the potential effect of BMI and smoking
status on TL differences between patients and healthy
controls. In our study, our findings point to higher
childhood abuse exposure in the patients as a mechanism for
reduced TL in patients compared with HC. Brain size dif-
ferences between groups tend to be small,20,22,35 and are thus
easily influenced by several factors, including the above.
To conclude, our study demonstrates significantly
shorter TL in SZ and BD and shows that TL is sensitive to
stressful life events. Further studies are needed to identify
the underlying biological mechanisms of this relationship.
Acknowledgements
This study was funded by grants from the South-Eastern Norway Health
Authority (#2017060) and the Narsad Young Investigator Award to Monica Aas
(#22388). The study was also funded by the Research Council of Norway
(#22327), the KG Jebsen Stiftelsen,
Author details
1NORMENT K.G Jebsen Centre for Psychosis Research, Institute of Clinical
Medicine, University of Oslo, and Division of Mental Health and Addiction, Oslo
University Hospital, Oslo, Norway. 2Department of Neurology, Oslo University
Hospital, Oslo, Norway. 3Department of Psychology, University of Oslo, Oslo,
Norway. 4Department of Medical Genetics, Oslo University Hospital, Oslo,
Norway. 5NORMENT, KG Jebsen Centre for Psychosis Research, Department of
Clinical Science, University of Bergen, Bergen, Norway. 6NIHR Newcastle
Biomedical Research Centre & Unit, Ageing Research Laboratories, Institute of
Neurosciences, Newcastle University, Campus for Ageing and Vitality,
Newcastle upon Tyne, UK. 7Department of Psychiatric Research,
Diakonhjemmet Hospital, Oslo, Norway. 8Department of Clinical Neuroscience,
Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden
Author contributions
M.A., T.E. and O.A.A. wrote the first draft. C.M.-R. performed the qPCR analyses.
L.A. and S.D. contributed to the Biobank & genetics analysis. All authors read,
contributed and approved the final paper.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Supplementary Information accompanies this paper at (https://doi.org/
10.1038/s41398-019-0432-7).
Received: 27 September 2018 Revised: 9 January 2019 Accepted: 24
January 2019
References
1. Aubert, G. & Lansdorp, P. M. Telomeres and aging. Physiol. Rev. 88, 557–579
(2008).
2. Blackburn, E. H. Switching and signaling at the telomere. Cell 106, 661–673
(2001).
3. Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse
transcriptase, in aplastic anemia. N. Engl. J. Med. 352, 1413–1424 (2005).
4. Blasco, M. A. Telomere length, stem cells and aging. Nat. Chem. Biol. 3,
640–649 (2007).
5. Hemann, M. T., Strong, M. A., Hao, L. Y. & Greider, C. W. The shortest telomere,
not average telomere length, is critical for cell viability and chromosome
stability. Cell 107, 67–77 (2001).
6. Samper, E., Flores, J. M. & Blasco, M. A. Restoration of telomerase activity
rescues chromosomal instability and premature aging in Terc-/- mice with
short telomeres. EMBO Rep. 2, 800–807 (2001).
Aas et al. Translational Psychiatry            (2019) 9:97 Page 6 of 7    97 
7. Collins, K. & Mitchell, J. R. Telomerase in the human organism. Oncogene 21,
564–579 (2002).
8. Lin, P. Y. Shortened leukocyte telomere length in patients with schizophrenia
is related to disease status. Schizophr. Res. 168, 597–598 (2015).
9. Lima, I. M. et al. Analysis of telomere attrition in bipolar disorder. J. Affect Disord.
172C, 43–47 (2014).
10. Maurya et al. Shorter leukocyte telomere length in patients at ultra high risk for
psychosis. Eur. Neuropsychopharmacol. 27, 538–542 (2017).
11. Berk, M. et al. Staging in bipolar disorder: from theoretical framework to clinical
utility. World Psychiatry 16, 236–244 (2017).
12. Maurya, P. K. et al. Leukocyte telomere length variation in different stages of
schizophrenia. J. Psychiatr. Res. 96, 218–223 (2018).
13. Pepper, G. V., Bateson, M. & Nettle, D. Telomeres as integrative markers of
exposure to stress and adversity: A systematic review and meta-analysis. R Soc
Open Sci. 5, 180744 (2018).
14. Epel, E. S. et al. Accelerated telomere shortening in response to life stress. Proc.
Natl. Acad. Sci. U. S. A 101, 17312–17315 (2004).
15. Price, L. H., Kao, H. T., Burgers, D. E., Carpenter, L. L. & Tyrka, A. R. Telomeres and
early-life stress: an overview. Biol. Psychiatry 73, 15–23 (2013).
16. Shalev, I. et al. Exposure to violence during childhood is associated with
telomere erosion from 5 to 10 years of age: a longitudinal study. Mol. Psy-
chiatry 18, 576–581 (2013b).
17. Tyrka, A. R. et al. Alterations of mitochondrial DNA copy number and telomere
length with early adversity and psychopathology. Biol. Psychiatry 79, 78–86
(2016).
18. Church, C. A. O. A., Lorentzen, S. & Melle, I. & Aas, M. Childhood Trauma and
Minimization/Denial in People with and without a Severe Mental Disorder.
Front Psychol. 8, 1276 (2017).
19. Alnaes, D., et al. Thedark side of the mean: brain structural heterogeneity in
schizophrenia and its polygenic risk. BioRXiv. Preprint at: https://doi.org/
10.1101/407890 (2018).
20. Hibar, D. P. et al. Cortical abnormalities in bipolar disorder: an MRI analysis of
6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol.
Psychiatry 23, 932–942 (2018).
21. Moberget, T. et al. Cerebellar volume and cerebellocerebral structural covar-
iance in schizophrenia: a multisite mega-analysis of 983 patients and 1349
healthy controls. Mol. Psychiatry 23, 1512–1520 (2018).
22. van Erp, T. G. M. et al. Cortical brain abnormalities in 4474 individuals with
schizophrenia and 5098 control subjects via the enhancing neuro imaging
genetics through meta analysis (ENIGMA) Consortium. Biol. Psychiatry 84,
644–654 (2018).
23. King, K. S. et al. Effect of leukocyte telomere length on total and regional brain
volumes in a large population-based cohort. JAMA Neurol. 71, 1247–1254
(2014).
24. Diagnostic and statistical manual of mental disorders (4th edn., Text Revision,
2009).
25. Ventura, J., Liberman, R. P., Green, M. F., Shaner, A. & Mintz, J. Training and
quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P).
Psychiatry Res. 79, 163–173 (1998).
26. Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale
(PANSS) for schizophrenia. Schizophr. Bull. 13, 261–276 (1987).
27. Pedersen, G., Hagtvet, K. A. & Karterud, S. Generalizability studies of the global
assessment of functioning-split version. Compr. Psychiatry 48, 88–94 (2007).
28. Bernstein, D. P. et al. Initial reliability and validity of a new retro-
spective measure of child abuse and neglect. Am. J. Psychiatry 151,
1132–1136 (1994).
29. Aas, M. et al. Interplay between childhood trauma and BDNF val66met var-
iants on blood BDNF mRNA levels and on hippocampus subfields volumes in
schizophrenia spectrum and bipolar disorders. J. Psychiatr. Res 59, 14–21
(2014).
30. MacDonald, K. et al. Minimization of childhood maltreatment is common and
consequential: results from a large, multinational sample using the childhood
trauma questionnaire. PLoS. One. 11, e0146058 (2016).
31. MacDonald, K., Thomas, M. L., MacDonald, T. M. & Sciolla, A. F. A perfect
childhood? Clinical correlates of minimization and denial on the childhood
trauma questionnaire. J. Interpers. Violence 30, 988–1009 (2015).
32. Arai, Y. et al. Inflammation, but not telomere length, predicts successful ageing
at extreme old age: a longitudinal study of semi-supercentenarians. EBioMe-
dicine. 2, 1549–1558 (2015).
33. IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0.
Armonk, NY: IBM Corp.
34. Cohen, J. Statistical Power Analysis for the Behavioral Sciences. (Academic Press,
New York, 1977).
35. Rimol, L. M. et al. Cortical thickness and subcortical volumes in schizophrenia
and bipolar disorder. Biol. Psychiatry 68, 41–50 (2010).
36. Shalev, I., Entringer, S. & Wadhwa, P. D. Stress and telomere biology: a lifespan
perspective. Psychoneuroendocrinology 38, 1835–1842 (2013a).
37. Eitan, E., Hutchison, E. R. & Mattson, M. P. Telomere shortening in neurological
disorders: an abundance of unanswered questions. Trends Neurosci. 37,
256–263 (2014).
38. Bitter, I. et al. Mortality and the relationship of somatic comorbidities to
mortality in schizophrenia. A nationwide matched-cohort study. Eur. Psychiatry
45, 97–103 (2017).
39. Osby, U., Westman, J., Hallgren, J. & Gissler, M. Mortality trends in cardiovascular
causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987-
2010. Eur. J. Public Health 26, 867–871 (2016).
40. Freund, A., Orjalo, A. V., Desprez, P. Y. & Campisi, J. Inflammatory networks
during cellular senescence: causes and consequences. Trends Mol Med 16,
238–246 (2010).
41. Leboyer, M., Oliveira, J., Tamouza, R. & Groc, L. Is it time for immunopsychiatry
in psychotic disorders?. Psychopharmacology (Berl) 233, 1651–1660 (2016).
42. Morch, R. H. et al. Inflammatory evidence for the psychosis continuum model.
Psychoneuroendocrinology 67, 189–197 (2016).
43. Aas, M. et al. Childhood maltreatment severity is associated with elevated C-
reactive protein and body mass index in adults with schizophrenia and bipolar
diagnoses. Brain Behav. Immun. 65, 342–349 (2017).
44. Elvsashagen, T. et al. The load of short telomeres is increased and associated
with lifetime number of depressive episodes in bipolar II disorder. J. Affect
Disord. 135, 43–50 (2011).
45. Daniali, L. et al. Telomeres shorten at equivalent rates in somatic tissues of
adults. Nat. Commun. 4, 1597 (2013).
46. Dlouha, D., Maluskova, J., Kralova Lesna, I., Lanska, V. & Hubacek, J. A. Com-
parison of the relative telomere length measured in leukocytes and eleven
different human tissues. Physiol. Res. 63(Suppl 3), S343–S350 (2014).
47. Fisher, H. L. et al. Reliability and comparability of psychosis patients’ retro-
spective reports of childhood abuse. Schizophr. Bull. 37, 546–553 (2011).
48. Newbury, J. B. et al. Measuring childhood maltreatment to predict early-adult
psychopathology: Comparison of prospective informant-reports and retro-
spective self-reports. J. Psychiatr. Res. 96, 57–64 (2018).
49. Reuben, A. et al. Lest we forget: comparing retrospective and prospective
assessments of adverse childhood experiences in the prediction of adult
health. J. Child Psychol. Psychiatry 57, 1103–1112 (2016).
Aas et al. Translational Psychiatry            (2019) 9:97 Page 7 of 7    97 
